The stock fell 4%, or 10p, to 240p after Exane BNP Paribas analyst Mia Strauss cut her rating to ‘underperform’ from ‘neutral’.Read More
You might also be interested in reading Bankman-Fried Lawsuits Expose FTX’s ‘Special Treatment’ of Alameda Research.